Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
Q&A: Rifaximin plus or minus lactulose reduces ED visits for hepatic encephalopathy
Rifaximin plus or minus lactulose compared with lactulose alone correlated with a decrease in ED health care utilization in patients with hepatic encephalopathy, according to a presentation at the ACG Annual Scientific Meeting.
Undiagnosed anxiety present in 17% of patients with cirrhosis
Using a cirrhosis-centric model, researchers found a high prevalence for anxiety in patients with cirrhosis, according to a presentation at The Liver Meeting Digital Experience.
Log in or Sign up for Free to view tailored content for your specialty!
Pegbelfermin improves markers of fibrosis in NASH
Pegbelfermin was safe and effective in improving markers of steatosis, fibrosis and inflammation among patients with nonalcoholic steatohepatitis with stage 3 fibrosis, according to a presentation at The Liver Meeting Digital Experience.
Increased fatty liver disease awareness needed to mitigate burden among young adults
Increased awareness is needed to mitigate burden fatty liver disease and modifiable risk factors among adolescents and young adults, according to research presented at The Liver Meeting Digital Experience.
COVID-19 vaccination decreases hospitalization rates in patients with cirrhosis
COVID-19 vaccination correlated with a decreased risk for hospitalization among patients with cirrhosis and other high-risk comorbidities, according to research presented at The Liver Meeting Digital Experience.
COVID-19 vaccine protection ‘lower and slower’ in patients with cirrhosis
Protection provided by the mRNA COVID vaccinations is slower to build to efficacy and lower overall in patients with cirrhosis as compared to unvaccinated controls, according to a presentation at The Liver Meeting Digital Experience.
Younger age, tobacco use link to lower COVID-19 vaccination rates
Among patients with cirrhosis, younger age, active tobacco use, fewer medical comorbidities and residence in the southern United States correlated with decreased rates of COVID-19 vaccination.
End-of-treatment HBsAg links to clinical HBV relapse rate
Higher end-of-treatment hepatitis B e-antigen level correlated with nucleos(t)ide clinical relapse but did not correlate with relapse severity regardless of HBsAg level among patients with chronic hepatitis B virus, according to research.
AGA issues guidelines for coagulation disorder management
The AGA published clinical practice guidelines in Gastroenterology for the management of coagulation disorders among patients with cirrhosis.
ACIP recommends universal hepatitis B vaccination for adults aged 19 to 59 years
The CDC’s Advisory Committee on Immunization Practices voted unanimously, 15-0, on Wednesday to recommend hepatitis B vaccination for all adults aged 19 to 59 years.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read